Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
16:00:02 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 85.21 USD | +1.15% |
|
+0.07% | -0.05% |
| Market Cap | 49.12B 43.86B 40.81B 37.12B 70.08B 4,753B 70.38B 491B 192B 2,423B 184B 180B 7,777B | P/E 2026 * |
34.3x | P/E 2027 * | 25.6x |
|---|---|---|---|---|---|
| Enterprise Value | 45.48B 40.62B 37.79B 34.37B 64.9B 4,402B 65.18B 455B 178B 2,244B 171B 167B 7,202B | EV / Sales 2026 * |
6.73x | EV / Sales 2027 * | 5.91x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Xetra
| EWL | Delayed | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.15% | ||
| 1 week | +0.07% | ||
| Current month | -1.29% | ||
| 1 month | -1.80% | ||
| 3 months | -7.59% | ||
| 6 months | +9.43% | ||
| Current year | -0.05% |
| 1 week | 82.42 |  | 87.88 |
| 1 month | 82.42 | | 89.7 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.15% | +0.07% | +15.24% | +16.87% | 49.12B | |
| +0.93% | +0.49% | +25.38% | +32.63% | 243B | |
| +1.08% | +2.69% | +8.57% | +0.50% | 155B | |
| +2.06% | +8.17% | -1.31% | +42.35% | 150B | |
| +1.64% | +0.31% | -55.21% | -20.58% | 61.93B | |
| +2.30% | +3.38% | -17.09% | -19.05% | 48.78B | |
| +1.41% | +1.65% | +24.83% | +50.53% | 48.08B | |
| +3.96% | +8.34% | +3.33% | +38.46% | 47.95B | |
| +1.08% | +2.01% | +31.05% | +61.37% | 42.62B | |
| +5.14% | +1.88% | +196.37% | +100.43% | 42B | |
| Average | +2.08% | +2.73% | +23.11% | +30.35% | 88.81B | |
| Weighted average by Cap. | +1.68% | +2.70% | +16.58% | +27.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.04B 5.62B 5.11B 9.65B 655B 9.69B 67.62B 26.5B 334B 25.4B 24.84B 1,071B | 7.43B 6.64B 6.18B 5.62B 10.61B 719B 10.65B 74.33B 29.12B 367B 27.91B 27.3B 1,177B |
| Net income | 1.44B 1.28B 1.19B 1.08B 2.05B 139B 2.06B 14.35B 5.62B 70.81B 5.39B 5.27B 227B | 1.9B 1.69B 1.58B 1.43B 2.71B 184B 2.72B 18.98B 7.43B 93.64B 7.13B 6.97B 300B |
| Net Debt | -3.63B -3.24B -3.02B -2.74B -5.18B -351B -5.2B -36.31B -14.23B -179B -13.63B -13.34B -575B | -5.19B -4.64B -4.32B -3.93B -7.41B -503B -7.44B -51.94B -20.35B -256B -19.51B -19.08B -823B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-09 | US$85.21 | +1.15% | 3,890,502 |
| 26-10-08 | US$84.24 | -1.80% | 6,522,221 |
| 26-10-07 | US$85.78 | -0.81% | 3,508,088 |
| 26-10-06 | US$86.48 | -0.86% | 3,383,228 |
| 26-10-05 | US$87.23 | +2.44% | 3,315,848 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
